Cwm, LLC Karuna Therapeutics, Inc. Transaction History

Cwm, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$161.01 - $317.85 $18,838 - $37,188	117 Added 75.48%	272 $86,000
Q3 2023 Oct 11, 2023	BUY	$164.66 - $218.08 $3,622 - $4,797	22 Added 16.54%	155 $26,000
Q2 2023 Aug 03, 2023	BUY	$176.32 - $240.22 $8,992 - $12,251	51 Added 62.2%	133 $29,000
Q1 2023 Apr 28, 2023	SELL	$161.33 - $204.36 $11,777 - $14,918	-73 Reduced 47.1%	82 $15,000
Q4 2022 Feb 01, 2023	BUY	$191.53 - $236.82 $18,195 - $22,497	95 Added 158.33%	155 $30,000
Q3 2022 Oct 27, 2022	BUY	$123.79 - $277.42 $4,208 - $9,432	34 Added 130.77%	60 $13,000
Q2 2022 Jul 28, 2022	BUY	$93.97 - $143.33 $2,067 - $3,153	22 Added 550.0%	26 $3,000
Q1 2022 Apr 21, 2022	BUY	$98.9 - $132.37 $395 - $529	4 New	4 $1,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.